Juliessa M Pavon

Dr. Juliessa M Pavon

Duke University, Durham, California, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2019 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
JPJuliessa M Pavon
Juliessa M Pavon
RSRichard J. Sloane
Richard J. Sloane
CPCarl F. Pieper
Carl F. Pieper
CCCathleen S. Colón‐Emeric
Cathleen S. Colón‐Emeric
HCHarvey J. Cohen
Harvey J. Cohen
SHSusan N. Hastings
Susan N. Hastings

1 April 2010 in Maturitas
Verified
Journal Article
Closed access
JPJuliessa M Pavon
Juliessa M Pavon
HWH.E. Whitson
H.E. Whitson
MOM.S. Okun
M.S. Okun

6 May 2014 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
JPJuliessa M Pavon
Juliessa M Pavon
YZYanfang Zhao
Yanfang Zhao
EMEleanor McConnell
Eleanor McConnell
SHS. Nicole Hastings
S. Nicole Hastings

23 March 2021 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
JPJuliessa M Pavon
Juliessa M Pavon
LFLaura Jane Fish
Laura Jane Fish
CCCathleen S. Colón‐Emeric
Cathleen S. Colón‐Emeric
KHKatherine Hall
Katherine Hall
MMMiriam C. Morey
Miriam C. Morey
SHS. Nicole Hastings
S. Nicole Hastings

9 November 2023 in Journal of the American Geriatrics Society
Verified
Journal Article
Open access
AAArmando Silva Almodóvar
Armando Silva Almodóvar
MKMichelle S. Keller
Michelle S. Keller
JLJiha Lee
Jiha Lee
HMHemalkumar B. Mehta
Hemalkumar B. Mehta
VMVeena Manja
Veena Manja
ALAmy M. Linsky
Amy M. Linsky
Deprescribing is the intentional dose reduction or discontinuation of a medication. The development of deprescribing interventions should take into consideration important organizational, interprofessional, and patient‐specific barriers that can be further complicated by the presence of multiple prescribers involved in a patient's care. Patients who receive care from an increasing number of prescribers may experience disruptions in the timely transfer of relevant healthcare information, increasing the risk of exposure to drug–drug interactions and other medication‐related problems. Furthermore, the fragmentation of healthcare information across health systems can contribute to the refilling of discontinued medications, reducing the effectiveness of deprescribing interventions. Thus, deprescribing interventions must carefully consider the unique characteristics of patients and their prescribers to ensure interventions are successfully implemented. In this special article, an international working group of physicians, pharmacists, nurses, epidemiologists, and researchers from the United States Deprescribing Research Network (USDeN) developed a socioecological model to understand how multiple prescribers may influence the implementation of a deprescribing intervention at the individual, interpersonal, organizational, and societal level. This manuscript also includes a description of the concept of multiple prescribers and outlines a research agenda for future investigations to consider. The information contained in this manuscript should be used as a framework for future deprescribing interventions to carefully consider how multiple prescribers can influence the successful implementation of the service and ensure the intervention is as effective as possible.

1 June 2018 in Journal of Hospital Medicine
Verified
Journal Article
Closed access
PDF file
JPJuliessa M Pavon
Juliessa M Pavon
RSRichard J. Sloane
Richard J. Sloane
CPCarl F. Pieper
Carl F. Pieper
CCCathleen S. Colón‐Emeric
Cathleen S. Colón‐Emeric
HCHarvey J. Cohen
Harvey J. Cohen
SHSusan N. Hastings
Susan N. Hastings
*Address for correspondence and reprint requests: Juliessa M. Pavon, MD, Duke University Health System, Division of Geriatrics, Box 3003, Durham, NC 27710; Tele